Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Mark J Selby"'
Autor:
Mark J Selby, John J Engelhardt, Robert J Johnston, Li-Sheng Lu, Minhua Han, Kent Thudium, Dapeng Yao, Michael Quigley, Jose Valle, Changyu Wang, Bing Chen, Pina M Cardarelli, Diann Blanset, Alan J Korman
Publikováno v:
PLoS ONE, Vol 11, Iss 11, p e0167251 (2016)
[This corrects the article DOI: 10.1371/journal.pone.0161779.].
Externí odkaz:
https://doaj.org/article/96849ae8f269431fa5d720767c21f010
Autor:
Mark J Selby, John J Engelhardt, Robert J Johnston, Li-Sheng Lu, Minhua Han, Kent Thudium, Dapeng Yao, Michael Quigley, Jose Valle, Changyu Wang, Bing Chen, Pina M Cardarelli, Diann Blanset, Alan J Korman
Publikováno v:
PLoS ONE, Vol 11, Iss 9, p e0161779 (2016)
The monoclonal antibodies ipilimumab (anti-CTLA-4) and nivolumab (anti-PD-1) have shown remarkable antitumor activity in an increasing number of cancers. When combined, ipilimumab and nivolumab have demonstrated superior activity in patients with met
Externí odkaz:
https://doaj.org/article/e4cbf86cb6a84748be5b341a365cb284
Autor:
Alan J. Korman, Mark J. Selby, Diann Blanset, R. Todd Bunch, Heidi Leblanc, Neysa Garner, Susan Wong, Sujata Singh, Mohan Srinivasan, Michelle Kuhne, Yi Wu, Candy Garcia, Diane Feingersh, Haichun Huang, Xi-Tao Wang, Minhua Han, Kent B. Thudium, Changyu Wang
PDF file - 25K, Figure S5. Effect of nivolumab on CD8+ T-cell subsets and DCs in PBMCs from nivolumab-treated cynomolgus monkeys.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3afeb590b18bc2205b3661f639ca33c
https://doi.org/10.1158/2326-6066.22537295
https://doi.org/10.1158/2326-6066.22537295
Autor:
Alan J. Korman, Mark J. Selby, Diann Blanset, R. Todd Bunch, Heidi Leblanc, Neysa Garner, Susan Wong, Sujata Singh, Mohan Srinivasan, Michelle Kuhne, Yi Wu, Candy Garcia, Diane Feingersh, Haichun Huang, Xi-Tao Wang, Minhua Han, Kent B. Thudium, Changyu Wang
PDF file - 376K, Figure S2. Epitope of nivolumab on human PD-1.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b853d4530e61228723451974fc3c28ae
https://doi.org/10.1158/2326-6066.22537304.v1
https://doi.org/10.1158/2326-6066.22537304.v1
Autor:
Alan J. Korman, Mohan Srinivasan, Timothy Chen, Karla A. Henning, Michael Quigley, John J. Engelhardt, Mark J. Selby
PDF file - 102K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a78834acb42bbd09b0c532e9cc23c8a
https://doi.org/10.1158/2326-6066.22536218.v1
https://doi.org/10.1158/2326-6066.22536218.v1
Autor:
Alan J. Korman, Mark J. Selby, Diann Blanset, R. Todd Bunch, Heidi Leblanc, Neysa Garner, Susan Wong, Sujata Singh, Mohan Srinivasan, Michelle Kuhne, Yi Wu, Candy Garcia, Diane Feingersh, Haichun Huang, Xi-Tao Wang, Minhua Han, Kent B. Thudium, Changyu Wang
PDF file - 400K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77e844640ae1ffeb1fc6f84395d28dbf
https://doi.org/10.1158/2326-6066.22537292
https://doi.org/10.1158/2326-6066.22537292
Autor:
Alan J. Korman, Mark J. Selby, Diann Blanset, R. Todd Bunch, Heidi Leblanc, Neysa Garner, Susan Wong, Sujata Singh, Mohan Srinivasan, Michelle Kuhne, Yi Wu, Candy Garcia, Diane Feingersh, Haichun Huang, Xi-Tao Wang, Minhua Han, Kent B. Thudium, Changyu Wang
PDF file - 22K, Figure S3. Nivolumab inhibits PD-1 interaction with PD-L1 and PD-L2.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::171e64e5c6eda8b06e46db9ba0ec0274
https://doi.org/10.1158/2326-6066.22537301.v1
https://doi.org/10.1158/2326-6066.22537301.v1
Autor:
Alan J. Korman, Mark J. Selby, Diann Blanset, R. Todd Bunch, Heidi Leblanc, Neysa Garner, Susan Wong, Sujata Singh, Mohan Srinivasan, Michelle Kuhne, Yi Wu, Candy Garcia, Diane Feingersh, Haichun Huang, Xi-Tao Wang, Minhua Han, Kent B. Thudium, Changyu Wang
PDF file - 239K, Figure S4. A, Expression of PD-1 in CD4 T cells during mixed lymphocyte reaction (MLR). B, Expression of PD-1 and PD-L1 during stimulation of peripheral blood mononuclear cells (PBMC) by superantigen SEB.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c943bf1ae098479376b53e375616e33
https://doi.org/10.1158/2326-6066.22537298
https://doi.org/10.1158/2326-6066.22537298
Autor:
Robert D. Schreiber, Alan J. Korman, Elaine R. Mardis, Robert F. Graziano, Mark J. Selby, Jasreet Hundal, Sang Hun Lee, Cora D. Arthur, Matthew M. Gubin, Jeffrey P. Ward, Takuro Noguchi
Antibody blockade of programmed death-1 (PD-1) or its ligand, PD-L1, has led to unprecedented therapeutic responses in certain tumor-bearing individuals, but PD-L1 expression's prognostic value in stratifying cancer patients for such treatment remain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::499ace0d0a9694d639e0c27216094086
https://doi.org/10.1158/2326-6066.c.6548426.v1
https://doi.org/10.1158/2326-6066.c.6548426.v1
Autor:
Robert D. Schreiber, Alan J. Korman, Elaine R. Mardis, Robert F. Graziano, Mark J. Selby, Jasreet Hundal, Sang Hun Lee, Cora D. Arthur, Matthew M. Gubin, Jeffrey P. Ward, Takuro Noguchi
Supplementary Figure S1. Genomic sequence of the PD-L1 locus and expression of immunogenic neoantigens in T3deltaPDL1 lines. Supplementary Figure S2. Expression of PD-L1 and neoantigens in the escape T3deltaPDL1 cells. Supplementary Figure S3. PD-L1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93ac53f562615ebe64dd48e6852f54cc
https://doi.org/10.1158/2326-6066.22537385
https://doi.org/10.1158/2326-6066.22537385